EUCODIS Bioscience GmbH, a Vienna, Austria-based provider of customized enzymes to the pharmaceutical, chemical, and other industries, raised €2m.
The company’s existing investors Pontis Capital, Wiener Wachstumsfonds, IBG, and ARAX participated in the round.
EUCODIS Bioscience will use these funds to add new enzyme families to its product portfolio and to accelerate the development of international markets.
At the same time, the company is also expanding its manufacturing capacity in pace with growing customer demand for its novel enzymes.
FinSMEs
03/03/2010